161 related articles for article (PubMed ID: 23653172)
1. Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI(2)).
Barnes GD; Kaatz S; Winfield J; Gu X; Haymart B; Kline-Rogers E; Kozlowski J; Beasley D; Almany S; Leyden T; Froehlich JB
J Thromb Thrombolysis; 2014; 37(2):171-6. PubMed ID: 23653172
[TBL] [Abstract][Full Text] [Related]
2. Stroke risks and patterns of warfarin therapy among atrial fibrillation patients post radiofrequency ablation: A real-world experience.
Zhang J; Liu X; Liu X; Yin X; Wang Y; Lu X; Yang X
Medicine (Baltimore); 2017 Nov; 96(47):e8762. PubMed ID: 29381974
[TBL] [Abstract][Full Text] [Related]
3. Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI
Hughey AB; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Ahsan S; Kaatz S; Froehlich JB; Barnes GD
J Thromb Thrombolysis; 2018 Oct; 46(3):316-324. PubMed ID: 29948756
[TBL] [Abstract][Full Text] [Related]
4. Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation.
Dakay K; Chang AD; Hemendinger M; Cutting S; McTaggart RA; Jayaraman MV; Chu A; Panda N; Song C; Merkler A; Gialdini G; Kummer B; Lerario MP; Kamel H; Elkind MSV; Furie KL; Yaghi S
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):192-197. PubMed ID: 28918087
[TBL] [Abstract][Full Text] [Related]
5. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
6. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation.
Mtwesi V; Amit G
Med Clin North Am; 2019 Sep; 103(5):847-862. PubMed ID: 31378330
[TBL] [Abstract][Full Text] [Related]
7. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
8. The changing characteristics of atrial fibrillation patients treated with warfarin.
Putnam A; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; Froehlich JB; Barnes GD
J Thromb Thrombolysis; 2015 Nov; 40(4):488-93. PubMed ID: 26130229
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation incrementally increases dementia risk across all CHADS
Graves KG; May HT; Jacobs V; Bair TL; Stevens SM; Woller SC; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Peter Weiss J; Jared Bunch T
Am Heart J; 2017 Jun; 188():93-98. PubMed ID: 28577686
[TBL] [Abstract][Full Text] [Related]
10. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
11. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly.
Guiot A; Jongnarangsin K; Chugh A; Suwanagool A; Latchamsetty R; Myles JD; Jiang Q; Crawford T; Good E; Pelosi F; Bogun F; Morady F; Oral H
J Cardiovasc Electrophysiol; 2012 Jan; 23(1):36-43. PubMed ID: 21806701
[TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
15. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
16. Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan - Insight From the ANAFIE (All Nippon AF In Elderly) Registry.
Hiasa KI; Kaku H; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Ikeda T; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Tsutsui H
Circ J; 2020 Feb; 84(3):388-396. PubMed ID: 31969518
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation.
Yaghi S; Liberman AL; Henninger N; Grory BM; Nouh A; Scher E; Giles J; Liu A; Nagy M; Kaushal A; Azher I; Fakhri H; Espaillat KB; Asad SD; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Trivedi T; Ishida K; Frontera J; Lord A; Furie K; Keyrouz S; de Havenon A; Mistry E; Leon Guerrero CR; Khan M
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104888. PubMed ID: 32414583
[TBL] [Abstract][Full Text] [Related]
18. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
